Yahoo Web Search

Search results

    • Clene (NASDAQ: CLNN) Presents Extended Survival Data at 2024 ENCALS Meeting

      Digital Journal· 5 days ago

      ...NASDAQ: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, presented new long-term CNM-Au8...